Health Conditions

Kidney Health

Other NamesAcute Kidney Injury

Natural Remedies10

Ingredients143

Table of contents

Other Names

Acute Kidney InjuryAcute Renal InjuryCardiorenal SyndromeChronic Kidney DiseaseChronic Renal DiseaseChronic Renal FailureDiabetic NephropathyEnd-Stage Kidney DiseaseEnd-Stage Renal DiseaseGlomerular DiseaseGlomerulonephritisHypertensive NephropathyKidney and Urologic DiseasesKidney CareKidney DiseaseKidney DiseasesKidney DisorderKidney DysfunctionKidney Failure, AcuteKidney Failure, ChronicKidney FunctionKidney Function TestsKidney ImpairmentKidney Replacement TherapyKidney WellnessNephritic SyndromeNephritisNephroangiosclerosisNephrologyNephropathyNephrosclerosisNephrotic SyndromePolycystic Kidney DiseaseRenal and Urinary DisordersRenal CareRenal DiseaseRenal DiseasesRenal DisorderRenal DysfunctionRenal Failure, AcuteRenal Failure, ChronicRenal FunctionRenal Function TestsRenal HealthRenal ImpairmentRenal InsufficiencyRenal Insufficiency, ChronicRenal MedicineRenal Replacement TherapyRenal WellnessUrologic Diseases

Synopsis

Kidney Health: A Nutritional and Natural-Health Reference

1. Definition and Physiological Context

"Kidney health" refers to the proper functioning of the kidneys — organs that filter blood, remove waste, and balance the body's fluids. The renal system consists of the kidneys, ureters, and urethra, and its overall function is to filter approximately 200 litres of fluid a day from renal blood flow, allowing toxins, metabolic waste products, and excess ions to be excreted while keeping essential substances in the blood. The kidney regulates plasma osmolarity by modulating the amount of water, solutes, and electrolytes in the blood; it ensures long-term acid-base balance; produces erythropoietin, which stimulates red blood cell production; produces renin for blood pressure regulation; and carries out the conversion of vitamin D to its active form.

The kidneys receive approximately 20–25% of cardiac output, corresponding to 1,200 mL/min of renal blood flow. The filtration fraction is typically 20%, meaning the glomerular filtration rate (GFR) is approximately 120 mL/min (180 L per day) in an average 60 kg person.

1.1 Structural Organization

Each kidney contains more than a million filtering units called nephrons. A nephron is functionally subdivided into a filtration unit called the renal corpuscle or glomerulus and a segmented tubular resorption compartment. Renal tubules reabsorb and return water, nutrients, and minerals the body needs, remove waste including excess acid and fluids, and pass waste through the kidneys' collecting chambers to leave the body as urine.

Filtered fluid travels through the proximal convoluted tubule, loop of Henle, and distal convoluted tubule before exiting into common collecting ducts shared by many nephrons. The renal cortex is the kidney's outer layer, where nephrons begin, and it also creates the hormone erythropoietin.

1.2 Kidney Disease: Definition and Staging

Chronic kidney disease (CKD) is a condition in which the kidneys are damaged or have a structural problem that prevents them from filtering blood the way they should. CKD is formally defined by the presence of kidney damage or decreased kidney function for at least three months, irrespective of the cause.

CKD is classified into five stages: Stage 1 (eGFR >90 + ACR >30): 3.5%; Stage 2 (eGFR 60–89 + ACR >30): 3.9%; Stage 3 (eGFR 30–59): 7.6%; Stage 4 (eGFR 29–15): 0.4%; and Stage 5 (eGFR <15): 0.1%. End-stage renal disease (ESRD) is the final stage of CKD, defined by a GFR of less than 15 mL/min/1.73 m², often necessitating renal replacement therapy such as dialysis or kidney transplantation.

1.3 How Kidney Disease Presents

Most people in the early stages of CKD do not have symptoms, and many people have no symptoms until their kidney disease is advanced. For many people, the only way to know if they have CKD is to get their kidneys checked with blood and urine tests. As many as 9 in 10 adults who have CKD are not aware they have the disease.

People with CKD may develop swelling (edema), which can happen when the kidneys cannot remove extra fluid and salt from the body. Edema can occur in the legs, feet, ankles, or less often in the hands or face, and is more common when kidney disease is very advanced or when there is significant protein leaking into the urine. Metabolic abnormalities including hyperphosphatemia, secondary hyperparathyroidism, hypocalcemia, and dyslipidemia are seen in advanced CKD patients.

2. Epidemiology

CKD is a global health burden with a high economic cost to health systems and is an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associated with increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of life.

In a systematic review and meta-analysis including 100 studies comprising 6,908,440 patients, the global mean CKD prevalence across all five stages was 13.4% (95% CI: 11.7–15.1%), and stages 3–5 combined was 10.6% (9.2–12.2%). In the United States, the prevalence of CKD increases dramatically with age: it is 6% in persons 18 to 44 years, 12% in those 45 to 64 years, and 34% in those 65 or older. The cumulative incidence of end-stage renal disease is approximately 50% higher in males than in females.

3. Contributing and Associated Factors

3.1 Non-Modifiable Risk Factors

Risk factors are classified into non-modifiable factors that cannot be changed, and modifiable factors. Non-modifiable risk factors include age, sex, and heredity (including race). The most important risk factors for chronic kidney disease include age, arterial hypertension, diabetes, obesity, proteinuria, dyslipidemia, and environmental risk factors such as dietary salt intake.

3.2 Modifiable Risk Factors

Diabetes and Hypertension: Studies indicate that 20–40% of those with diabetes will eventually develop CKD. Smoking, obesity, hypertension, and diabetes mellitus can lead to kidney disease, and an uncontrolled diabetic and/or hypertensive patient can easily and quickly progress to end-stage kidney disease.

Obesity: Obesity causes CKD by promoting insulin resistance, inflammation, and elevated glomerular filtration rate, all of which can eventually cause kidney damage. Obesity exacerbates both hypertension and diabetes, two leading risk factors for CKD.

Tobacco Smoking: Tobacco smoking has been identified as a risk factor for incident CKD. Although the mechanism is uncertain, smoking may lead to insulin resistance, which might explain a large effect on risk of albuminuria. The harmful effects of smoking may also be mediated by endothelial cell dysfunction, inducing advanced glycation end products due to glycotoxins present in cigarettes, and increased vascular permeability.

Nephrotoxic Exposures: Exposure to heavy metals, excessive alcohol consumption, smoking, and the use of analgesic medications constitute risks. Experiencing acute kidney injury, a history of cardiovascular disease, hyperlipidemia, metabolic syndrome, hepatitis C virus, HIV infection, and malignancy are further risk factors.

Physical Inactivity: A cross-sectional study of over 65,000 Norwegian adults showed that obesity, smoking, and physical inactivity are all associated with CKD, with dose-response relationships found for all three risk factors. Increased risk was seen for BMI greater than 30 kg/m², smoking greater than 25 pack-years, and less than one hour of intensive physical activity per week.

4. Dietary Factors in Kidney Health

4.1 Overall Dietary Patterns

A "healthy" dietary pattern characterized by high intake of vegetables, fruits, fish, low-fat milk, and whole grains was associated with a lower risk of CKD in meta-analysis; the highest compared with the lowest category of healthy dietary pattern showed an odds ratio of 0.69 (CI: 0.57–0.84; P=0.0001) in a random-effects model across 17 studies.

Comprehensive analysis of evidence from experimental and observational studies indicates that both the Mediterranean Diet and the Dietary Approaches to Stop Hypertension (DASH) exert significant preventive and protective effects against CKD.

Strong adherence to the DASH diet — characterized by low intake of red and processed meat and high intake of fruits, vegetables, and low-fat dairy products — was associated with a 14% lower risk of CKD compared with those with the lowest adherence.

4.2 Dietary Protein: Source and Amount

Western diets with an increased content of processed red meat have been associated with accelerated progression of CKD, up to three times higher than normally expected (−3 mL/min/1.73 m² eGFR decline) and increased proteinuria. In the Atherosclerosis Risk in Communities (ARIC) study, the highest quartile of red and processed meat intake was associated with a 22% higher risk of CKD (95% CI: 1.07–1.40; P-trend = 0.02) compared with the lowest quartile.

A high protein intake causes vasodilation of the afferent arteriole, increasing intraglomerular pressure and thus the progression of glomerulosclerosis, while low-protein diets reduce proteinuria, improve blood pressure control, and reduce the rate of decline in kidney function.

The KDIGO 2012 CKD guideline recommends lowering protein intake to 0.8 g/kg per day for those with a GFR of <30 mL/min/1.73 m² (CKD stages G4 and G5), irrespective of the presence or absence of diabetes mellitus.

Further studies have demonstrated that higher plant protein intake was associated with a lower risk of subsequent CKD. Plant proteins are less likely to induce glomerular hyperfiltration than animal proteins. Plant-based diets may reduce the production of gut-derived uremic toxins by increasing the intake of fiber, and are useful for correcting metabolic acidosis and hyperphosphatemia.

4.3 Sodium

The KDOQI 2020 Clinical Practice Guideline for Nutrition in CKD recommends limiting sodium intake to less than 100 mmol/d (or <2.3 g/d) to reduce blood pressure and improve volume control. High salt intake is closely associated with the progression of CKD. When the urine sodium-to-creatinine ratio increases by 100 mmol/L, the risk of CKD developing into ESRD increases by 1.61 times.

4.4 Phosphorus

While more evidence-based studies are warranted, the customary nutrition prescription remains satisfactory with the exception of vitamin D and phosphate, where additional research is urgently needed given the potential for adverse outcomes in the CKD patient.

4.5 Potassium

Higher vegetable intake is associated with higher potassium intake: both dietary factors were consistently associated with fewer kidney outcomes. The mechanism is likely, at least in part, through the intermediary diseases that are themselves risks for CKD. Higher potassium intake was associated with reduced incident CKD and GFR decline. In adults with CKD 3-5D or post-transplantation, it is reasonable to adjust dietary potassium intake to maintain serum potassium within the normal range, per KDOQI guidance.

4.6 Dietary Fiber

In observational studies on a general population, higher fibre intake was correlated with better kidney function, less inflammation, and a reduced risk of mortality. Epidemiological studies also show that consumption of fresh fruit, whole grains, low-fat dairy products, and vegetable proteins such as legumes, soy, and oilseeds appear to be protective factors against the development of kidney disease.

4.7 Hydration

A growing body of evidence supports a protective effect of increased water intake on kidney function. As the effective therapy for preventing kidney stones, increased water intake clears sodium, urea, and osmoles. Guidelines recommend increasing water intake to achieve a urine volume of at least 2.0 to 2.5 litres a day to prevent stone recurrence. Several observational studies reveal that high water intake may protect the kidneys.

By reducing vasopressin secretion, increasing water intake may have a beneficial effect on renal function in patients with all forms of CKD and in those at risk of CKD. In one Australian cohort, CKD was significantly associated with low intake of plain water (adjusted OR 2.36; 95% CI 1.10–5.06), but not with low intake of other beverages, providing additional evidence for a potentially protective effect of plain water on the kidney.

Recurrent dehydration and heat stress have been identified as a common risk factor in epidemics of CKD among agricultural workers in several regions globally. Experimental models have confirmed that recurrent heat stress and water restriction can lead to CKD, mediated by hyperosmolarity that activates renal injury pathways.

5. Key Nutrients Studied in Relation to Kidney Health

5.1 Vitamin D

Vitamin D deficiency is strongly associated with CKD progression, bone mineral disorders, secondary hyperparathyroidism (sHPT), and increased mortality. The kidneys carry out the conversion of vitamin D to its active form. However, the clinical effectiveness of vitamin D and calcium supplementation individually or combined in CKD remains uncertain. Despite evidence suggesting that vitamin D supplementation may reduce parathyroid hormone (PTH), findings are inconsistent. Evidence strength: Vitamin D deficiency in CKD is well-established; intervention trials show mixed results, and evidence certainty by GRADE assessment remains low to moderate.

5.2 Omega-3 Polyunsaturated Fatty Acids

In a randomized controlled clinical trial carried out on 120 CKD patients undergoing hemodialysis, the intervention group received 3 capsules of 1,000 mg omega-3 fatty acid supplement daily for 2 months, compared with placebo. Omega-3 supplementation significantly improved blood urea nitrogen (BUN) and creatinine (Cr) levels after adjustment for confounders. However, no significant effect was found on serum levels of sodium, potassium, calcium, and phosphorus.

Other systematic reviews have reported that omega-3 polyunsaturated fatty acids may help improve kidney function, though evidence consistency is variable. Evidence strength: Preliminary to moderate; benefits on specific renal biomarkers observed in some RCTs, but large definitive trials are lacking.

5.3 Coenzyme Q10

A systematic review using a GRADE approach examined evidence for coenzyme Q10 (CoQ10) among other nutritional supplements and their effects on CKD progression prevention. Previous systematic reviews on the relationship between nutrition supplements and CKD were inconsistent and evidence certainty was lacking. Evidence strength: Preliminary; current evidence is insufficient to support broad recommendations for CoQ10 in CKD.

5.4 Potassium and Magnesium

In a systematic review and meta-analysis on modifiable lifestyle factors, higher potassium intake was associated with reduced incident CKD and GFR decline, adding to the growing evidence base for the protective association of potassium intake in chronic conditions. Plant-based diets increase magnesium intake, which may prevent vascular calcification in CKD patients. Evidence strength: Potassium associations are supported by observational and meta-analytic data; magnesium evidence in CKD is preliminary, mostly from mechanistic and observational studies.

5.5 Dietary Acid Load

Lower dietary acid loads — for example, higher intake of fruits and vegetables and fewer meats and cheeses — have been reported to prevent CKD progression in clinical studies. Although limited, experimental trials for the treatment of metabolic acidosis in CKD with fruits and vegetables show outcomes comparable to oral bicarbonate. Evidence strength: Moderate; supported by observational data and small clinical trials.

6. Botanicals and Natural Ingredients: Traditional Use and Scientific Evidence

The following profiles strictly separate traditional use from scientific evidence. It should be noted that a PubMed-indexed review of 184 health websites found that the ten most commonly cited plant ingredients claiming to be beneficial in kidney diseases were uva ursi, dandelion, parsley, corn silk, juniper, celery, buchu, horsetail, marshmallow, and stinging nettle. In contrast to their claims, these substances were not adequately studied in humans, and available animal studies showed detrimental effects and potential drug interactions with commonly used CKD medications.

6.1 Bearberry / Uva Ursi (Arctostaphylos uva-ursi)

Traditional Use: Uva ursi is an herbal product derived from the fresh or dried leaves of the plant Arctostaphylos uva-ursi, or bearberry. Uva ursi has been used historically to treat dysuria, cystitis, urethritis, and kidney and bladder stones, and has also been recommended for inducing diuresis. It has a long history of use in European and North American Indigenous herbal medicine.

Phytochemistry: Uva ursi leaves contain several phytochemicals including ursolic acid, tannic acid, gallic acid, hydroquinone glycosides (mainly arbutin), and flavonoids. The active component is suspected to be hydroquinone, particularly arbutin and methyl arbutin, which may have anti-inflammatory and antiseptic activities that are excreted in the urine.

Regulatory and Official Monograph Status: The European Medicines Agency's Committee on Herbal Medicinal Products (HMPC) concluded that, on the basis of its long-standing use, bearberry leaf preparations can be used for treating symptoms of mild, recurrent infections in the lower urinary tract, such as a burning sensation and/or frequent urination. These medicines should only be used in adult women after serious conditions have been excluded by a doctor. The benefit-risk ratio of uva ursi folium extract has been considered favorable for the claimed indication and dosage by the German Commission E, the HMPC, ESCOP, and WHO monographs.

Scientific Evidence: Women with kidney disorders are contraindicated from taking bearberry leaf medicines according to the EMA. Evidence strength: Traditional use recognition by multiple official monograph bodies for lower urinary tract symptoms; not studied in CKD; contraindicated in kidney disorders.

6.2 Cranberry (Vaccinium macrocarpon)

Traditional Use: Cranberry has a long history of use among Indigenous North American peoples and in folk medicine for preventing and treating urinary tract complaints. It was traditionally consumed as juice or the whole berry.

Scientific Evidence: A meta-analysis of 23 trials with 3,979 participants found that cranberry-based product intake can significantly reduce the incidence of urinary tract infections (UTIs) in susceptible populations (risk ratio 0.70; 95% CI: 0.59–0.83; P<0.01). The analysis identified a relative risk reduction of 32%, 45%, and 51% in women with recurrent UTIs, children, and patients using indwelling catheters, respectively. A-type proanthocyanidins (PACs) contained in cranberries are reported to prevent Escherichia coli from adhering to uroepithelial cells in the urinary tract. According to several recent guidelines on UTI management, the efficacy of cranberry supplementation as adjuvant therapy has not yet reached a definitive conclusion, and the quality of evidence was characterized as low. Evidence strength: Moderate for UTI prevention in susceptible populations; the mechanism is plausible; effect on kidney function per se has not been well-established.

6.3 Chanca Piedra / Stone Breaker (Phyllanthus niruri)

Traditional Use: In traditional Amazonian medicine, the entire plant — roots, stems, leaves, and flowers — is used as herbal medicine. Indigenous healers have employed chanca piedra for hundreds, possibly thousands of years, primarily for kidney stones, gallstones, and various urinary and liver ailments.

Scientific Evidence: Phyllanthus niruri (P. niruri), or "stone breaker," is a plant used for years in Brazil to treat urinary calculi. A prospective study was conducted to evaluate the effect of P. niruri on the urinary metabolic parameters of 56 patients with kidney stones <10 mm over a 12-week intervention period. Phyllanthus niruri has demonstrated the capacity to contribute to kidney stone dissolution and reduce formation; clinical studies suggest that its extracts can lower stone size and frequency by inhibiting crystal aggregation and promoting increased urine output. Evidence strength: Preliminary to moderate; supported by small human clinical trials and in vitro studies; larger, high-quality RCTs are lacking.

6.4 Astragalus (Astragalus membranaceus)

Traditional Use: Astragalus has been a fundamental herb in Traditional Chinese Medicine (TCM) for centuries, used as a tonic to strengthen what TCM characterizes as "defensive qi," and historically prescribed for conditions including edema and kidney weakness.

Scientific Evidence: Over 100 chemical constituents have been isolated from A. membranaceus, including flavonoids, saponins, polysaccharides, and amino acids. Studies in animal and cellular models have demonstrated that Astragalus possesses potent protective effects in the kidney, and clinical studies have shown that Astragalus can improve kidney function and reduce proteinuria, though the quality of these studies had not been systematically assessed. A systematic review on Astragalus injection for hypertensive renal damage found that it showed protective effects in hypertensive renal damage patients, although available studies were not adequate to draw a definitive conclusion due to low quality of included trials. More rigorous clinical trials with high quality are warranted. Evidence strength: Preliminary; some positive signals from clinical studies on proteinuria and kidney function, but evidence quality is low; most high-quality systematic reviews call for more rigorous trials.

6.5 Nettle Leaf (Urtica dioica)

Traditional Use: Stinging nettle (Urtica dioica) has a long history of use in herbal traditions for urinary tract health. It has been used across European and North American herbal traditions as an aquaretic (increasing urine output) and for alleviating symptoms of urinary discomfort.

Scientific Evidence: In a PubMed-indexed review, stinging nettle was identified among the most commonly claimed botanicals for kidney health; however, the available substances were not adequately studied in humans, and available animal studies showed detrimental effects and potential drug interactions with commonly used CKD medications. Evidence strength: Very limited human data; nettle may carry risks for persons with CKD due to potassium content and possible renal stress in impaired kidneys.

6.6 Dandelion (Taraxacum officinale)

Traditional Use: Dandelion root is a common herb used traditionally for kidney and urinary support, including as a mild diuretic. Its use in European herbal medicine for "flushing" the kidneys and urinary tract has been documented for centuries.

Scientific Evidence: Most evidence for these traditional kidney herbs, including dandelion, is mixed and limited, with much of it based on traditional use, animal studies, or small human trials. Evidence strength: Insufficient; human clinical evidence for renal endpoints is lacking.

6.7 Horsetail (Equisetum arvense)

Traditional Use: Equisetum arvense, commonly known as horsetail or field horsetail, is one of the oldest medicinal plants still in widespread use. It has been used historically in European herbal medicine as a diuretic and to support urinary tract function.

Scientific Evidence: As with other botanicals claimed for kidney benefit, horsetail was not found to be adequately studied in humans; available animal studies showed detrimental effects and potential drug interactions with CKD medications. Evidence strength: Insufficient; recognized in some traditional monographs but human clinical evidence for kidney-specific outcomes is lacking.

7. Dietary and Lifestyle Factors: Summary of Authoritative Evidence

7.1 Reducing Processed and Red Meat

Several observational studies have shown that red and processed meat has been associated with increased risk of CKD as well as faster progression in those with preexisting CKD. Patients following the DASH diet, with low meat consumption and increased vegetables, fruits, and low-fat dairy products, had a 14% lower risk of developing CKD.

7.2 Increasing Plant Foods and Fiber

In patients with chronic kidney disease, several observational studies have shown that high adherence to different healthy dietary patterns rich in plant foods and fibers — including the Healthy Eating Index-2015, Alternative Healthy Eating Index-2010, alternate Mediterranean diet, DASH diet, and plant-based indices — is associated with a delay in CKD progression and improved survival. Plant-based diets may reduce the production of gut-derived uremic toxins by increasing fiber intake, and are useful for correcting metabolic acidosis and hyperphosphatemia.

7.3 Sodium Restriction

High salt intake leads to renal impairment in various ways, including increasing transforming growth factor (TGF)-β1 production and enhancing oxidative stress and inflammatory responses in the kidney. Clinical trials have shown that in patients with CKD, salt reduction has additional beneficial effects on renal outcomes including reduction of proteinuria, independent of blood pressure-lowering effects.

7.4 Adequate Hydration with Plain Water

The type of fluid intake may be important, as some studies suggest that intake of water is protective whereas sugary beverages may accelerate kidney injury in experimental models. Guidelines recommend increasing water intake to achieve a urine volume of at least 2.0 to 2.5 litres a day to prevent stone recurrence.

7.5 Physical Activity

The harmful lifestyle factors for kidney disease risk — including tobacco smoking, physical inactivity, and dietary patterns — clearly support a public health message to address modifiable behaviors for preventing kidney disease as well as cardiovascular disease. A combination of dietary changes and increased physical activity can help achieve a healthy weight, which is particularly important given that obesity exacerbates both hypertension and diabetes.

7.6 Weight Management

Being obese is a known risk factor for hypertension and diabetes, and also plays a separate role in the onset of CKD. In patients who are overweight or obese, weight management is crucial. Obesity exacerbates both hypertension and diabetes, two leading risk factors for CKD.

7.7 Avoiding Tobacco

The evidence supports a public health message to avoid tobacco smoking to prevent kidney disease as well as cardiovascular disease. Dose-response relationships between pack-years of smoking and CKD risk have been identified in large population studies.

References

Natural Remedies

Remedy 1

Stay Well-Hydrated with Water: Adequate daily water intake is one of the simplest and most effective ways to support kidney health, helping the kidneys flush out waste products and prevent the concentration of minerals that can lead to kidney stones. Aim for at least 6–8 glasses of plain water per day, and increase intake during hot weather or physical activity. Herbal teas and diluted fruit juices can also contribute to overall fluid intake.

Remedy 2

Dandelion Root Tea: Dandelion root has been used for centuries as a natural diuretic, promoting urine production and helping to flush out waste and toxins from the kidneys. Steep 1–2 teaspoons of dried dandelion root in hot water for 10 minutes and drink 1–2 cups per day. Its gentle cleansing effect makes it a longstanding staple in herbal kidney-support traditions.

Remedy 3

Nettle Leaf Infusion: Nettle leaf supports kidney health through its diuretic properties and rich antioxidant content, helping to promote urine flow and reduce fluid retention. Brew a cup of dried nettle leaf tea 1–2 times daily to tap into its anti-inflammatory and nutrient-supporting benefits. It has been used in traditional herbal medicine for generations as a kidney tonic.

Remedy 4

Turmeric (Curcumin): Turmeric contains curcumin, a potent anti-inflammatory and antioxidant compound that may help reduce inflammation and oxidative stress in kidney tissue. Add half a teaspoon of turmeric powder to warm milk, soups, or meals daily; pairing it with a pinch of black pepper improves absorption. It is a widely used spice in Ayurvedic approaches to kidney and overall health support.

Remedy 5

Lemon Water: The National Kidney Foundation suggests adding about 4 ounces of concentrated lemon juice to a glass of water daily to help support kidney health. Lemon contains citrate, a natural compound that may help prevent kidney stone formation by binding with calcium in the urine. Drinking lemon water each morning is a simple, low-cost daily practice.

Remedy 6

Low-Sodium, Whole-Foods Diet: A high-sodium diet can worsen kidney strain over time by increasing blood pressure and causing fluid buildup. Reducing salt intake by swapping processed and packaged foods for whole grains, fresh vegetables, and natural seasonings like garlic and herbs helps lower the burden on the kidneys. Cabbage, red grapes, and berries are particularly kidney-friendly food choices rich in antioxidants.

Remedy 7

Milk Thistle: Milk thistle is rich in silymarin, a powerful antioxidant that helps protect kidney cells from oxidative damage and reduces inflammation. It can be taken as a standardized supplement capsule or brewed as a tea, and has been used in both Western herbalism and Ayurvedic practice for kidney and liver protection. Its protective properties make it a popular choice in natural kidney-support regimens.

Remedy 8

Regular Gentle Exercise: Consistent moderate physical activity — such as walking, swimming, or yoga — helps maintain a healthy weight, regulate blood pressure, and reduce the risk of kidney-damaging conditions like diabetes and hypertension. Aim for at least 30 minutes of low-to-moderate movement most days of the week. Even short daily walks are beneficial for maintaining healthy circulation and renal function.

Remedy 9

Prioritize Restorative Sleep: Sleep plays a critical role in allowing the body and kidneys to rest and recover; poor sleep disrupts hormone balance and can interfere with how kidneys filter toxins. Aim for 7–8 hours of consistent, restful sleep each night, and create a calming bedtime routine by limiting screen time and caffeine before bed. Restorative sleep supports the body's natural detox cycle, helping kidneys function more efficiently.

Remedy 10

Stress Management Through Mindfulness: Chronic stress raises blood pressure and contributes to inflammation, both of which can negatively affect kidney function over time. Incorporating daily mindfulness practices such as deep breathing, meditation, or gentle stretching can reduce stress-related spikes in blood pressure and ease systemic inflammation. Even 10–15 minutes of mindful breathing or guided meditation per day can offer meaningful support for kidney and overall health.

Ingredients

These ingredients are often used in alternative medicine to support kidney health.

acaciaScientific
A body of clinical evidence, including controlled trials and a published GARDS study, shows that acacia gum supplementation improves renal biomarkers (serum creatinine, urea, creatinine clearance) in chronic kidney disease (CKD) and end-stage renal failure patients. Its antioxidative and anti-inflammatory properties appear to slow renal dysfunction progression.
activated charcoalScientific
Activated charcoal (AC) adsorbs gut-derived uremic toxins such as indoxyl sulfate (IS) and p-cresyl sulfate, reducing their systemic accumulation in CKD. Multiple RCTs in CKD and ESRD patients show significant reductions in serum urea, phosphorus, and IS with oral AC supplementation. Specialized oral charcoal adsorbents (e.g., AST-120/Kremezin) have been specifically studied for slowing CKD progression.
ALA (alpha-lipoic acid)Scientific
Alpha-lipoic acid (ALA) is a potent endogenous antioxidant with both fat- and water-soluble properties, studied for nephroprotection in diabetic nephropathy, contrast-induced nephropathy, and drug-induced kidney damage. Multiple clinical trials have shown ALA supplementation improves creatinine clearance, reduces proteinuria, and lowers oxidative stress markers in diabetic nephropathy patients.
alismaScientific
Alisma orientale (Ze Xie) is a cornerstone herb in Traditional Chinese Medicine used for millennia to support kidney function, clear 'excess heat,' and promote water metabolism. Modern research published in Frontiers in Pharmacology (2018) demonstrated its nephroprotective effects in CKD models through regulation of lipid metabolism and reduction of tubular interstitial fibrosis. It is a key ingredient in classical TCM formulas such as Liu Wei Di Huang Wan, which has been studied clinically for reducing kidney failure risk in diabetic patients.
ashitabaScientific
A 2024 rat study demonstrated that Angelica keiskei reduced cisplatin-induced nephrotoxicity by lowering serum creatinine, urea nitrogen, and KIM-1 while suppressing NF-κB and COX-2. Earlier rat feeding studies showed no kidney pathology even at excessive doses. No human renal trials exist.
astaxanthinScientific
A randomized double-blind placebo-controlled trial (6 mg/day, 8 weeks) in renal transplant patients found astaxanthin was safely consumed without adverse effects on renal function. Preclinical evidence demonstrates astaxanthin protects against kidney oxidative damage; diabetic retinopathy cell studies confirm renal-parallel antioxidant pathways. However, dedicated human RCTs with renal endpoints are sparse.
astragalosideScientific
Astragalosides (particularly astragaloside IV) are the primary bioactive saponin glycosides of astragalus root, shown in preclinical studies to ameliorate kidney fibrosis on top of standard care (captopril) in CKD animal models. They are the active components underlying astragalus's renoprotective effects, documented in clinical and animal studies for CKD, diabetic nephropathy, and hypertensive renal damage.
astragalusScientific
Astragalus (Huang Qi, Astragalus membranaceus) is one of the most widely studied TCM herbs for chronic kidney disease (CKD). A 2024 multicenter RCT (ClinicalTrials.gov NCT03535935) in type 2 diabetic CKD patients showed add-on astragalus slowed eGFR decline by 4.6 mL/min/1.73m² per year over 48 weeks compared to standard care. A Cochrane systematic review also evaluated its use in CKD, noting potential to decrease serum creatinine and reduce proteinuria, though evidence quality was limited.
bananaScientific
Banana's potassium content supports kidney function by suppressing urinary calcium excretion, reducing the risk of kidney stones. Epidemiologic data from a Swedish prospective cohort study of 61,000 women support this association. Green banana products have also shown benefits for renal complications related to diabetes in clinical studies.
barberryScientific
A clinical RCT using Berberis vulgaris root extract in 80 T2DM patients evaluated renal biochemical parameters and found no significant adverse effects on kidney function. Barberry has been used traditionally as a diuretic to support kidney function.
barrenwortScientific
Icariin exerts nephroprotective effects in multiple animal models of kidney disease including diabetic nephropathy, acute kidney injury, IgA nephropathy, chronic kidney disease, and lupus nephritis. Mechanisms include anti-fibrotic, antioxidant, anti-apoptotic, and anti-inflammatory activity. Traditional TCM use of Epimedium explicitly includes kidney-tonifying (renal tonic) functions.
belleric myrobalanScientific
A randomized, double-blind, positive-controlled clinical trial (BMC Complement Med Ther 2020) demonstrated that aqueous T. bellirica extract (500–1000 mg twice daily, 24 weeks) significantly reduced serum uric acid and creatinine while improving eGFR in chronic kidney disease patients with hyperuricemia. An earlier clinical study also confirmed uric acid reduction. The extract's xanthine oxidase inhibitory activity is the proposed mechanism.
benfotiamineScientific
Benfotiamine has been tested specifically for diabetic nephropathy in a double-blind RCT (n=82). Despite significantly improving thiamine status, 12 weeks of 900 mg/day did not reduce urinary albumin excretion or KIM-1 — key markers of kidney damage. Animal models had previously shown prevention of incipient diabetic nephropathy.
berberineScientific
Berberine is a bioactive isoquinoline alkaloid found in plants such as barberry and Coptis chinensis, used in TCM and Ayurveda for over 2,000 years. Modern research demonstrates significant renoprotective effects across multiple kidney disorders including diabetic nephropathy, renal fibrosis, ischemia-reperfusion injury, and nephrotoxicity. A 2025 systematic review and meta-analysis of 26 animal studies found berberine significantly lowered serum creatinine, BUN, TGF-β1, and fibrosis area in models of renal fibrosis.
bicarbonateScientific
In chronic kidney disease (CKD) with metabolic acidosis, oral sodium bicarbonate supplementation is guideline-supported (KDIGO 2024) for correcting low serum bicarbonate and slowing CKD progression. Multiple RCTs and meta-analyses report improved estimated glomerular filtration rate (eGFR) with supplementation. However, trial evidence remains heterogeneous and sodium loading is a recognized concern.
black cuminScientific
Clinical trials and systematic reviews demonstrate N. sativa's nephroprotective effects, reducing creatinine, blood urea nitrogen, and progression of diabetic nephropathy. N. sativa also significantly reduced proteinuria in a randomised clinical trial in diabetic nephropathy patients.
boerhavia diffusaScientific
Boerhavia diffusa (Punarnava) is a foundational kidney herb in Ayurvedic medicine, used for thousands of years as a diuretic, anti-inflammatory, and renal regenerative herb. Scientific evidence includes animal studies showing its aqueous extract protects against kidney injury and oxidative stress, and a canine clinical study showing effects comparable to enalapril (an ACE inhibitor) in improving renal parameters including hemoglobin, potassium, phosphorus, and urinary proteins.
boxthorneScientific
LBPs exert renoprotective effects in multiple animal injury models (high-fat diet, lead toxicity, pancreatitis, sepsis-AKI, hyperuricemia). LBP reduces serum creatinine, BUN, and inflammatory markers in kidney injury models. Traditional Chinese medicine has used boxthorn as a kidney tonic for over 2,000 years.
carrotScientific
Animal studies demonstrate that carrot extract protects against drug-induced and sepsis-induced kidney injury through its antioxidant phytochemicals (carotenoids, phenolics, polyacetylenes). Gentamicin nephrotoxicity models show dose-dependent reduction in renal injury markers. Traditional use as a diuretic and for urinary conditions provides additional context.
caryophylleneScientific
BCP has demonstrated nephroprotective effects in rodent models of ischemia-reperfusion injury and cisplatin-induced nephrotoxicity via antioxidant and anti-inflammatory CB2 mechanisms. It is listed among BCP's established pharmacological activities in systematic reviews.
chaff flowerScientific
A. aspera has preclinical evidence for nephroprotective activity and is documented in multiple pharmacological studies as diuretic. Its root and seed extracts have been investigated in animal models of renal injury, with renal biomarker improvements reported.
chanca piedraScientific
Chanca piedra (Phyllanthus niruri, 'stone breaker') has been used in Amazonian and South Asian traditional medicine for kidney stones and urinary tract conditions for centuries. Multiple clinical studies support its traditional use: a RCT of 69 calcium stone-forming patients showed it normalizes elevated urinary calcium; another 56-patient study found improvements in urinary magnesium/creatinine ratios and potassium excretion; and clinical evidence supports its ability to inhibit calcium oxalate crystal aggregation and reduce stone size.
chinese salvia rootScientific
Danshen injection has been used clinically in China to treat renal diseases including acute renal failure and acute nephritis. Its antioxidant and anti-inflammatory properties reduce oxidative injury in the kidney. Preclinical studies show protection against iron-overload-induced kidney injury and cyclosporin-induced nephrotoxicity.
CoQ10 (coenzyme Q10)Scientific
Coenzyme Q10 (ubiquinol/ubiquinone) is an endogenous mitochondrial antioxidant with documented benefits in CKD, where CoQ10 deficiency has been observed. Clinical studies in CKD and hemodialysis patients show CoQ10 supplementation reduces oxidative stress markers, improves mitochondrial function in renal tubular cells, and some trials show modest improvements in creatinine clearance and GFR.
cordycepsScientific
Cordyceps sinensis (Dong Chong Xia Cao) is one of the most researched TCM fungi for CKD. A Cochrane systematic review and multiple clinical studies found Cordyceps preparations as adjuvant therapy showed potential to decrease serum creatinine, increase creatinine clearance, and reduce proteinuria in CKD patients. Clinical studies showed it can lower inflammatory markers and improve kidney function, particularly when combined with conventional ARB therapy.
cranberryScientific
Cranberry (Vaccinium macrocarpon) is supported by clinical research primarily for preventing urinary tract infections (UTIs) through inhibition of bacterial adhesion to the urinary tract wall, thereby reducing infection-related kidney stress. Proanthocyanidins in cranberry prevent bacterial adhesion to the bladder wall. It has also been linked to antilithogenic properties, potentially reducing calcium oxalate crystallization related to kidney stone formation.
curcuminScientific
Curcumin, the primary bioactive curcuminoid of turmeric, has demonstrated renoprotective effects in multiple preclinical studies and some clinical trials, particularly for diabetic nephropathy and CKD. It reduces renal inflammation and oxidative stress via NF-κB and Nrf2 pathways. A meta-analysis of RCTs in diabetic nephropathy patients showed curcumin supplementation improved kidney function markers.
d-alpha tocopherolScientific
Vitamin E (alpha-tocopherol) has been studied in CKD and ESRD populations, where its antioxidant and anti-inflammatory properties address the high oxidative stress burden of renal disease. The SPACE trial demonstrated cardiovascular benefit in ESRD patients, and vitamin E–coated hemodialyzers have shown hematological and oxidative stress benefits.
dandelionScientific
Dandelion (Taraxacum officinale) has a long history in European, Ayurvedic, and TCM traditions as a kidney and urinary tonic. A 2009 human pilot study found dandelion extract significantly increased urinary frequency and excretion volume, supporting its traditional use as a diuretic and kidney-flushing herb. Its diuretic action may support kidney filtration and waste elimination.
danshenScientific
Danshen (Salvia miltiorrhiza, Chinese Salvia root) is one of the most widely studied TCM herbs for kidney disease. Its active components tanshinone IIA, salvianolic acid A and B, and cryptotanshinone demonstrate antifibrotic, anti-inflammatory, and antioxidant nephroprotective effects. A PMC review identified it as one of five TCM herbs with sufficient clinical efficacy evidence for CKD, with clinical trials showing reductions in proteinuria and creatinine.
dodderScientific
Cuscuta chinensis is one of the most ancient and central kidney tonics in TCM, recorded since ~200 CE. Preclinical studies show that aqueous extracts of C. chinensis significantly recover renal functional parameters in ischemia/reperfusion-induced acute renal failure rats, including creatinine clearance and tubular damage markers. This is supported by folk medicine use for liver and kidney disorders across multiple cultures.
dogwoodScientific
Cornus officinalis is a principal TCM herb for kidney diseases and has been studied for nephroprotective effects, particularly in diabetic nephropathy. Animal studies show reductions in proteinuria and renal oxidative stress markers. Multiple PMC reviews confirm nephroprotective activity in preclinical models.
ellagic acidScientific
Ellagic acid is a polyphenol antioxidant found in pomegranate, berries, and other fruits with documented nephroprotective effects in preclinical studies. It protects against nephrotoxin-induced kidney damage (cisplatin, gentamicin), reduces oxidative stress in renal tissue, and attenuates inflammatory kidney injury. Pomegranate—a primary dietary source—has been studied clinically for reducing oxidative stress in hemodialysis patients.
enicostemma littoraleScientific
E. littorale treatment in 84 T2D patients produced significant improvement in kidney function parameters over three months. Animal studies confirm nephroprotective activity and reduction of renal cholesterol and triglyceride accumulation. In vivo nephroprotection data and clinical kidney function normalization are both documented.
eucommiaScientific
Eucommia has both traditional and modern scientific support for kidney health. A 2025 single-arm clinical trial showed significant SBP reduction in CKD patients, and preclinical studies demonstrate protection against diabetic nephropathy and renal fibrosis. The TCM framework explicitly identifies eucommia as a kidney tonic.
fisetinScientific
A 2025 systematic review across multiple databases found consistent preclinical evidence that fisetin protects against nephrotoxicity, drug-induced kidney injury, diabetic nephropathy, and lupus-induced nephropathy via antioxidant and anti-inflammatory mechanisms. Clinical evidence is absent.
forsythiaScientific
Preclinical research has identified nephroprotective properties of Forsythia suspensa, particularly forsythoside A, in models of sepsis-related acute kidney injury and nephrotoxicity. Pharmacological review literature characterizes nephroprotective activity as one of its documented activities. No human clinical trials specifically assessing kidney health endpoints have been published.
fu lingScientific
Poria cocos exerts renal-protective effects via its diuretic action, anti-inflammatory properties, and antioxidant activity in preclinical kidney injury models. Carboxymethylated polysaccharides reduced TNF-α, IL-6, and IL-1β in septic acute kidney injury rats. Triterpenoids from the surface layer have demonstrated protective effects in chronic kidney disease models.
ganodermaScientific
Traditional Chinese medicine has used Ganoderma to treat nephritis and support kidney function. A 2025 meta-analysis of 17 human RCTs found a significant reduction in serum creatinine with Ganoderma supplementation, and preclinical studies show renal protection.
gingerScientific
Ginger (Zingiber officinale) has documented anti-inflammatory and antioxidant properties through its active components gingerols and shogaols, which have been shown in preclinical studies to protect kidney tissue by modulating NF-κB inflammatory pathways and reducing oxidative stress. A 2022 review documented its bioactive components' anti-inflammatory effects modulating NF-κB and cytokine pathways relevant to kidney damage protection.
goldenrodScientific
The European Medicines Agency (EMA) recognizes goldenrod as a traditional herbal medicinal product for increasing urine output to support flushing of the urinary tract. Pharmacological studies confirm diuretic, anti-inflammatory, antispasmodic, and analgesic actions relevant to kidney and urinary tract health. Open non-randomized clinical studies show effectiveness in cystitis and urinary tract disorders over 2–4 weeks. Saponins in goldenrod are thought to increase renal blood flow and glomerular filtration.
gooseberryScientific
Amla supplementation has been shown to reduce age-related renal lipid accumulation in studies, and its high antioxidant content is mechanistically linked to prevention of oxidative renal injury. PMC literature documents amla's potential for preventing age-related kidney disease.
hesperidinScientific
Hesperidin demonstrates renoprotective effects in multiple preclinical models of kidney injury including nephrotoxin-induced, hypertension-related, and oxidative-stress-related renal damage. It reduces renal oxidative stress markers, serum ACE activity, and TGF-β1, and modulates angiotensin receptor expression to protect kidney function. Human clinical data specific to kidney endpoints are absent.
hibiscusScientific
Clinical and preclinical evidence supports nephroprotective effects of Hibiscus sabdariffa. An RCT in diabetic nephropathy patients found HS supplementation improved renal function markers including blood urea nitrogen, serum creatinine, and urine albumin. HS also demonstrated uricosuric effects in a human study and antiurolithiatic activity in animal models.
hydrangeaScientific
Multiple animal studies and in vitro experiments have investigated hydrangea extracts for renoprotective effects. Total coumarins from H. paniculata significantly reduced BUN and creatinine in cisplatin-induced and LPS-induced acute kidney injury mouse models. Skimmin specifically slowed progression of membranous glomerulonephritis in rats by reducing BUN, urinary albumin excretion, and immune complex deposition. No human trials exist.
indian gum arabic treeScientific
Clinical trials show gum arabic (Acacia arabica/senegal) supplementation improves renal biomarkers in chronic kidney disease and haemodialysis patients. A phase II trial and multiple studies documented reductions in urea, creatinine, and inflammatory markers. A 2023 systematic review and meta-analysis confirmed these findings.
indian sarsparillaScientific
Nephroprotective (renoprotective) activity of H. indicus root extracts is listed among its confirmed pharmacological properties in multiple published reviews. In vivo studies have shown protection of kidney tissue against oxidative stress and toxic insult, and the plant is classically used as a diuretic in Ayurveda.
l-carnitineScientific
The kidneys are a primary site of L-carnitine synthesis; renal disease leads to carnitine deficiency. The FDA has approved IV L-carnitine for carnitine deficiency in dialysis patients. In end-stage renal disease, carnitine deficiency contributes to anemia, fatigue, cardiomyopathy, and muscle weakness.
L-histidineScientific
Histidine is considered conditionally essential in chronic kidney disease (CKD), where plasma levels are consistently depressed. Low plasma histidine in CKD independently predicts protein-energy wasting, oxidative stress, inflammation, and greater mortality. Supplementation has shown benefit in uremic patients, and histidine-deficient diets exacerbate anemia in CKD.
lotus seedScientific
Lotus seedpod extract protected against cisplatin-induced renal injury in vitro and in vivo via antioxidant mechanisms. Lotus seed extract also protected kidney tissue from CCl4-induced oxidative damage in mice. In TCM, lotus seeds are assigned to the Kidney meridian and used to tonify kidney function.
methionine methylsulfonium chlorideScientific
MMSC has demonstrated nephroprotective activity in rat models of aminoglycoside-induced nephrotic syndrome and mouse models of streptozotocin-induced diabetic nephropathy. It improved kidney function parameters, reduced proteinuria, and modulated pro-inflammatory signaling in renal tissue. Evidence is entirely preclinical; no human kidney trials have been published.
milk thistleScientific
Milk thistle (Silybum marianum) and its active flavonolignan complex silymarin have documented nephroprotective properties beyond their well-known liver benefits. Clinical trials demonstrate that silymarin protects against nephrotoxicity from agents such as cisplatin (chemotherapy) and cyclosporine. Animal studies show silymarin reduces proteinuria and alleviates renal tissue damage in diabetic models, and adding it to renin-angiotensin system inhibitors significantly reduced urinary albumin excretion in diabetic nephropathy patients.
moringaScientific
Moringa oleifera has preclinical evidence for nephroprotective effects, demonstrating the ability to reduce kidney damage markers and oxidative stress in animal models. Rich in antioxidant flavonoids (quercetin, myricetin), kaempferol, and glucosinolates, it has been studied for protection against nephrotoxin-induced and diabetes-related kidney injury. In Ayurveda it is prescribed for kidney stone management and urinary health.
morusScientific
A clinical trial in 60 diabetic patients with kidney damage found M. alba supplementation improved antioxidant status and blood lipid profiles, suggesting a renoprotective effect. Preclinical studies and the 2023 PubMed review confirm Morus alleviates kidney damage in hyperglycaemic models.
NAC (N-acetyl cysteine)Scientific
N-Acetyl Cysteine (NAC) is a well-established nephroprotective agent, most notably for preventing contrast-induced nephropathy (CIN) in patients undergoing radiographic procedures. Multiple meta-analyses and clinical trials support its use to protect kidney function by replenishing glutathione, a key renal antioxidant. It is also studied for protection against cisplatin nephrotoxicity and as a supportive treatment in CKD.
naringinScientific
Naringin exerts nephroprotective effects against oxidative, toxic, and ischemic kidney injury in preclinical models, reducing creatinine, BUN, and inflammatory markers. It activates Nrf2 and suppresses NF-κB to protect renal tissue. A 2022 review confirmed naringin as a promising candidate for kidney dysfunction prevention; no human clinical trials have been published.
nettleScientific
Stinging nettle (Urtica dioica) is used traditionally across Europe, Ayurveda, and North American herbalism as a kidney tonic and diuretic. Its leaf and seed have different kidney-related properties: the leaf provides diuretic (aquaretic) and anti-inflammatory action, while the seed is considered a more direct kidney trophorestorative in Western herbal practice. Research highlights its anti-inflammatory and antioxidant compounds, linked to reduced oxidative stress associated with kidney damage.
okraScientific
Okra has been studied clinically in diabetic nephropathy patients. A 2024 RCT evaluated dried okra extract on lipid profile, renal function, and RAGE-related inflammatory genes in diabetic nephropathy. A separate triple-blind RCT assessed effects on glycemic control, inflammation, kidney function, and PPAR/TGF-β/Nrf-2 gene expression in nephropathy patients.
oleanolic acidScientific
OA protects against renal fibrosis, oxidative kidney damage, and diabetic nephropathy in multiple animal models. Mechanisms include Nrf2-mediated antioxidant enhancement, TGF-β/Smad pathway inhibition, and suppression of inflammatory cell infiltration. Protection against renal oxidative stress is also documented in diet-induced prediabetes models.
ophiopogonScientific
Ophiopogonin D and polysaccharide MDG-1 from O. japonicus both protect kidney function in diabetic nephropathy animal models, reducing markers of renal damage including creatinine, BUN, and fibrosis. O. japonicus polysaccharides are noted for renal protective activity in published reviews.
ophiopogon rootScientific
Preclinical studies demonstrate that Ophiopogon root constituents protect against diabetic nephropathy. MDG-1 polysaccharide (300 mg/kg, 12 weeks in KKAy mice) significantly reduced blood urea nitrogen, albumin, TGF-β1, and alleviated glomerular mesangial expansion and tubulointerstitial fibrosis. Ophiopogonin D reversed renal dysfunction markers in STZ-induced diabetic nephropathy rats, including serum creatinine, BUN, and kidney hypertrophy.
paederia foetidaScientific
P. foetida possesses documented nephroprotective activity, protecting the kidneys from diabetic and toxic insults. Preclinical studies show it reduces kidney inflammation via NF-κB inhibition, normalizes serum creatinine and BUN, and enhances renal antioxidant enzymes.
parsleyScientific
Parsley has documented nephroprotective and diuretic properties, supported by preclinical and limited human data. Its flavonoids and volatile oils increase urine output via Na+/K+-ATPase inhibition, reduce renal oxidative stress, and improve biomarkers of kidney function. A 2024 systematic review in Frontiers in Medicine consolidates both animal and limited human study findings.
phyllanthusScientific
Phyllanthus (principally P. niruri, P. amarus) is the genus from which chanca piedra (stone breaker) derives, with well-documented clinical evidence for kidney stone management and urinary tract health. Multiple clinical studies support its use for reducing kidney stone recurrence, modifying urinary metabolic risk factors for stones, and its traditional use in Ayurvedic, Amazonian, and South Asian medicine for renal health.
polyporusScientific
P. umbellatus is among the best-studied medicinal fungi for kidney health, showing nephroprotective, diuretic, and anti-fibrotic effects. Multiple in vivo studies and clinical prescriptions document its role in chronic renal failure, kidney fibrosis, and nephrotic edema.
pomegranateScientific
Pomegranate (Punica granatum) is rich in ellagitannins (punicalagins, ellagic acid), anthocyanins, and polyphenols with documented clinical evidence for kidney benefit in hemodialysis and CKD patients. A 1-year RCT in 101 hemodialysis patients found pomegranate juice significantly reduced inflammatory markers (CRP, IL-6, TNF-α), oxidative stress, and hospitalization rates. It also demonstrates antilithogenic effects by reducing urinary calcium oxalate crystallization.
potassiumScientific
Low dietary potassium intake is increasingly recognized as a risk factor for kidney injury and accelerated chronic kidney disease (CKD) progression. The kidney is the primary organ regulating potassium homeostasis, but potassium also reciprocally affects renal function. Higher potassium intake is associated with lower albuminuria and slower eGFR decline in population studies.
psylliumScientific
Psyllium is recognized as a suitable fiber supplement in chronic kidney disease (CKD) due to its low potassium and phosphorus content. Epidemiological data (NHANES III, n=14,543) link higher dietary fiber intake to reduced inflammation and CKD mortality. Preclinical CKD models show psyllium reduces serum creatinine, blood urea nitrogen, and uremic toxins (indoxyl sulfate) via the gut–kidney axis; clinical use in pre-dialysis CKD for constipation is supported by RCT evidence.
puerarinScientific
Puerarin is an isoflavone C-glycoside from kudzu root (Pueraria lobata), recognized as one of five TCM herbs with sufficient clinical evidence for CKD in a PMC review. It protects against diabetic nephropathy and CKD progression via antioxidant, anti-inflammatory, and antifibrotic mechanisms. Clinical and experimental studies demonstrate reductions in proteinuria, creatinine, and renal fibrosis markers.
punicalaginsScientific
Punicalagins are the primary polyphenolic ellagitannins in pomegranate, responsible for its potent antioxidant and anti-inflammatory effects documented in CKD and dialysis patients. They hydrolyze to ellagic acid and are metabolized to urolithins with nephroprotective properties. Clinical pomegranate studies demonstrating reduced inflammation and oxidative stress in hemodialysis patients are largely attributable to punicalagins as the dominant bioactive.
quercetinScientific
Quercetin is a ubiquitous flavonoid with well-documented antioxidant and anti-inflammatory properties that extend to nephroprotection. Multiple preclinical studies demonstrate its ability to reduce nephrotoxin-induced kidney damage, protect against diabetic nephropathy, and reduce renal fibrosis markers. Clinical studies in CKD and dialysis patients have shown reductions in inflammatory biomarkers and oxidative stress markers with quercetin supplementation.
rehmanniaScientific
Rehmannia glutinosa (Di Huang) is a principal kidney-supporting herb in TCM, used for over 1,500 years as a 'Kidney Yin tonic.' It is the principal ingredient in Liu Wei Di Huang Wan, one of the most prescribed TCM formulas for kidney-related conditions. Animal studies show nephroprotective effects in CKD models via modulation of intestinal microbiota and renal oxidative stress, and clinical population data support reduced kidney failure risk when used as part of standard TCM formulas.
rehmannia glutinosaScientific
Rehmannia is one of the most studied Chinese herbs for kidney support, with clinical evidence that Liuwei Dihuang formulas reduce proteinuria in diabetic nephropathy and chronic kidney disease. Rehmannia plus irbesartan decreased urinary protein in CKD patients. It is listed in the Pharmacopoeia of the People's Republic of China for kidney tonification.
reishi mushroomScientific
Reishi extracts demonstrate renoprotective effects in preclinical models, confirmed by MSKCC and peer-reviewed reviews. In vitro and in vivo studies show reishi reduces oxidative stress, inflammatory markers, and histological damage in kidney tissue. No standalone human RCTs on renal function have been published, but the preclinical mechanistic evidence is characterised as established by authoritative sources.
rhubarb rootScientific
Multiple human clinical trials and a meta-analysis demonstrate rhubarb root's ability to slow progression of chronic renal failure, reducing serum creatinine, blood urea nitrogen, uric acid, and proteinuria while improving GFR. A 2014 RCT and a 2023 meta-analysis of multiple trials confirm these findings.
rosmarinic acidScientific
Rosmarinic acid has shown renoprotective effects in preclinical models, protecting against oxidative damage, reducing inflammation in renal tissue, and being investigated in combined hypertension-diabetes-nephrolithiasis rat models. In hemodialysis contexts, RA-supplemented dialysate reduced pro-inflammatory cytokine production from human vascular endothelial cells. However, direct human RCTs for kidney outcomes are absent.
rutinScientific
Preclinical studies demonstrate rutin protects kidneys from oxidative damage, diabetic nephropathy, and drug-induced nephrotoxicity through antioxidant and anti-inflammatory mechanisms. No human clinical trials specifically targeting kidney outcomes with rutin have been identified.
salvianolic acidScientific
Salvianolic acids (A and B) are the primary water-soluble bioactive components of danshen (Salvia miltiorrhiza) with documented nephroprotective effects including reduction of renal fibrosis, anti-inflammatory activity, and antioxidant protection in the kidney. They are identified in authoritative reviews as key active components of one of the five TCM herbs with the strongest clinical evidence for CKD.
schisandrinsScientific
Schisandrin B and related schisandrins from Schisandra chinensis (Wu Wei Zi) have preclinical and some clinical evidence for nephroprotection, including protection against nephrotoxin-induced acute kidney injury. Wu Wei Zi is used in TCM as a kidney tonic herb and has been studied in the context of drug-induced and oxidative kidney damage.
sclerotiumScientific
Poria cocos sclerotium is classically used as a diuretic in TCM, with modern animal studies confirming diuretic and nephroprotective effects. Polysaccharides protect against acute kidney injury and chronic kidney disease via NF-κB and Nrf2 pathway modulation.
secoisolariciresinol diglucosideScientific
SDG has demonstrated renal protective effects in animal models of chemically induced nephrotoxicity (cadmium, benzo[a]pyrene), lupus nephritis, and polycystic kidney disease, reducing lipid peroxidation, inflammation, and renal injury markers. A review in PMC confirmed SDG interferes with lupus nephritis by delaying proteinuria onset and reducing renal inflammation.
silybinScientific
Silybin (silibinin) is the principal active flavonolignan component of silymarin (milk thistle extract) with documented direct nephroprotective effects. It has been specifically studied for protection against cisplatin, cyclosporine, and gentamicin nephrotoxicity. It prevents high glucose-induced oxidative stress and podocyte injury in vitro and in vivo, directly relevant to diabetic nephropathy.
silymarinScientific
Silymarin is the standardized flavonolignan complex from milk thistle (Silybum marianum) with documented clinical nephroprotective evidence. Clinical trials demonstrate silymarin protects against cisplatin-induced nephrotoxicity and reduces urinary albumin excretion in diabetic nephropathy patients when added to renin-angiotensin system inhibitors. Its primary mechanisms include Nrf2 activation, glutathione replenishment, and anti-inflammatory activity in renal tissue.
smilaxScientific
Smilax glabra has been used in TCM for nephritis and kidney conditions for centuries. Animal studies demonstrate that its flavonoid-rich fractions reduce uric acid nephropathy by lowering uric acid, reducing renal oxidative stress and inflammation, and modulating renal urate transporters. A historical report showed that sarsaparilla increased urinary excretion of uric acid in chronic nephritis patients.
soyScientific
In type 2 diabetic patients with nephropathy, soy protein substitution for animal protein significantly reduces proteinuria, urinary creatinine, blood urea nitrogen, and CRP in RCTs. Soy protein generates less renal acid load and fewer nephrotoxic metabolites than animal protein, supporting kidney function in CKD populations.
soy isoflavonesScientific
In patients with chronic kidney disease (CKD), soy protein containing isoflavones has been associated with reductions in proteinuria, serum creatinine, and CRP in predialysis populations. A meta-analysis of 12 RCTs supports a nephroprotective signal.
soybeanScientific
Clinical and mechanistic evidence supports that soy protein has renoprotective effects, particularly in chronic kidney disease (CKD). Soy protein has been shown to have direct renal effects that improve renal function, and soy intake is associated with improvements in antioxidant status and reduced systemic inflammation in CKD patients. Genistein prevents CKD development by inhibiting inflammation and fibrosis. Soy protein may lower blood pressure through decreased angiotensin-converting enzyme activity, indirectly protecting the kidneys.
SPMs (specialized pro-resolving mediators)Scientific
SPMs protect against kidney inflammation in diabetic nephropathy and acute kidney injury models. Reduced SPM levels have been associated with progressive renal dysfunction in human studies. Resolvins and protectins are produced in renal tissue and exert nephroprotective effects via macrophage modulation.
steviaScientific
A 9-month randomized, placebo-controlled clinical trial in 97 CKD patients found stevioside supplementation significantly reduced microalbuminuria, serum creatinine, serum uric acid, and inflammatory markers, and reduced blood pressure. Effects partially reversed during a 3-month washout period, indicating treatment dependence. Animal studies also document protective effects against renal damage.
sweet flagScientific
Animal studies (PMC, 2021) demonstrate nephroprotective activity of A. calamus, with improved urinary creatinine clearance, GFR, and histopathological kidney protection. Traditional use for kidney troubles is consistently documented across Ayurvedic and Unani systems.
tanshinoneScientific
Tanshinones (primarily tanshinone IIA and cryptotanshinone) are lipophilic diterpene quinones from danshen (Salvia miltiorrhiza), identified as key nephroprotective compounds in one of the most-studied TCM herbs for CKD. They inhibit renal fibrosis via TGF-β1/SMAD pathway suppression, reduce mesangial proliferation, and have anti-inflammatory and antioxidant effects documented in multiple animal and some clinical studies.
taurineScientific
Taurine is generally renoprotective in animal models, decreasing cellular damage and proteinuria following nephrotoxic insults. Taurine has been shown to influence several types of kidney disease including acute kidney injury, glomerulonephritis, and diabetic nephropathy, primarily in preclinical settings.
tinospora cordifoliaScientific
T. cordifolia exhibits nephroprotective activity in gentamicin-induced and diabetic nephropathy models, reducing creatinine, urea, and proteinuria markers. Animal studies confirm it protects against nephrotoxic agents via antioxidant and anti-inflammatory mechanisms.
turmericScientific
Turmeric (Curcuma longa) and its primary bioactive, curcumin, are well-studied for nephroprotective effects, particularly in diabetic nephropathy and CKD. Curcumin reduces renal inflammation via NF-κB pathway inhibition and activates Nrf2 antioxidant defenses. Clinical data in diabetic nephropathy patients show improvements in creatinine, BUN, and proteinuria. Turmeric/curcumin is recommended by multiple kidney health frameworks as an anti-inflammatory kidney-supportive herb.
adzuki beanTraditional
In TCM, adzuki bean (Chi Xiao Dou) is prescribed to promote diuresis, clear heat and dampness, and support kidney fluid metabolism; it is listed in the Chinese Pharmacopoeia for diuresis and swelling. Animal research shows adzuki bean seed coats protect against cisplatin-induced renal interstitial fibrosis via proanthocyanidins. Human clinical evidence for direct kidney protection is lacking.
aerva lanataTraditional
Aerva lanata is an Ayurvedic herb (Pashanabheda/Gorakhbuti) traditionally used in South Asian and African traditional medicine specifically for kidney stones, urinary tract infections, and diuresis. It has been documented in Ayurvedic pharmacopoeia for urinary system and kidney stone management for centuries, with supporting preclinical evidence for anti-urolithic and diuretic activity.
agrimonyTraditional
Agrimony is traditionally used for kidney inflammation (pyelonephritis) and is described in multiple European folk medicine traditions as beneficial for kidney and urinary diseases. Its diuretic, anti-inflammatory, and antimicrobial properties underpin this use. No clinical trials specific to kidney disease exist.
alfalfaTraditional
Alfalfa has longstanding traditional use for kidney disorders across Ayurvedic and early American herbal medicine, attributed to its purported diuretic and kidney-tonic effects. RxList and Drugs.com pharmacological monographs document kidney conditions as a traditional indication. No controlled human studies support this use.
anemarrhena asphodeloidesTraditional
In TCM, anemarrhena nourishes Kidney Yin and clears Kidney heat, and is incorporated in formulas addressing steaming bone disorder, nocturnal emissions, and Kidney yin deficiency syndromes. It is used traditionally to support kidney function as a diuretic and to address kidney-related symptoms.
asparagusTraditional
Asparagus has a long, well-documented traditional use across European, Asian, Chinese, and Persian medical traditions for kidney and urinary complaints, including inclusion in several national pharmacopoeias for kidney irrigation therapy. Modern animal data suggests nephroprotective and ACE-inhibitory effects relevant to kidney function, but formal human RCT evidence is absent.
banabaTraditional
Banaba leaves have been used in Philippine folk medicine for kidney-related conditions including kidney stones and kidney cleansing. Laboratory and animal studies indicate nephroprotective effects, with banaba extract reducing kidney damage markers in high-cholesterol/high-sugar diet models. No human clinical trials specifically addressing renal endpoints have been published.
basilTraditional
Basil has been used in Ayurveda and traditional medicine for kidney problems and urinary tract infections. Its diuretic properties are documented in traditional herbalism. Animal models show it does not exhibit nephrotoxicity at studied doses, but no clinical trials target kidney health as a primary outcome.
bearberryTraditional
Bearberry (Arctostaphylos uva-ursi) contains arbutin, which is hydrolyzed to hydroquinone in alkaline urine to exert urinary antiseptic effects. The European Medicines Agency (EMA) and German Commission E recognize bearberry leaf's traditional use for mild urinary tract infections, an application directly relevant to preventing infection-related kidney damage. It has been used in European folk medicine for urinary and kidney conditions for centuries.
birchTraditional
Birch leaf is formally recognised by EMA, ESCOP and the German Commission E for urinary tract irrigation including support of kidney health through promotion of urine flow in cases of renal gravel and minor infections. Birch buds are additionally used in Eastern European traditions as a kidney drainage remedy. Evidence is traditional with pharmacological plausibility.
bovine kidneyTraditional
Indigenous and ancestral healing traditions worldwide held that consuming the kidney of a healthy animal nourishes and supports the corresponding organ in humans—the principle of 'like supports like.' This practice is documented across Native American and other traditional cultures. No controlled human clinical trials support glandular bovine kidney supplementation for kidney health.
buchuTraditional
Buchu (Agathosma betulina and related species) is a South African herb with documented traditional use by the Khoikhoi and San peoples, and later adopted in European herbal medicine, as a urinary tract and kidney remedy. The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) and German Commission E recognize buchu's traditional use for increasing urinary output and treating minor urinary complaints.
burdockTraditional
Burdock root has a long traditional use as a kidney-supporting diuretic across European and TCM herbal medicine. The EMA recognizes it as a traditional herbal medicine to increase urine output, facilitating elimination during minor urinary tract infections and aiding the kidneys' natural filtration. Animal studies suggest it may reduce kidney stone risk by increasing urinary excretion.
cardamomTraditional
Cardamom is classified in Ayurvedic medicine as a diuretic and kidney tonic, used for renal calculi, kidney infections, and urinary clearance. Animal research has explored nephroprotective effects. A pharmacological study documented diuretic activity. Human clinical trials targeting kidney function are absent.
catjang cowpeaTraditional
Cowpea is described as mildly diuretic in the Ayurvedic tradition and has been used in folk medicine to manage mild edema, reflecting traditional recognition of kidney relevance. No human clinical evidence for kidney-specific protective effects has been found.
champignonTraditional
A US patent (US6261588) claims champignon mushroom extract for preventing or treating renal diseases including progressive renal failure and various nephritides. Human clinical trial safety data (12-week trial, 3 g/day) showed no adverse changes in kidney function tests. Champignon extract's reduction of blood ammonia and intestinal putrefaction products is proposed to reduce uremic burden on kidneys, but this endpoint has not been tested in dedicated human renal trials.
chickweedTraditional
Chickweed is traditionally used as a mild diuretic supportive of kidney and bladder function, helping eliminate excess uric acid, toxins, and waste via the urinary system. Traditional texts and herbalist monographs consistently document this use. No clinical studies are available.
cleaversTraditional
Cleavers is deeply documented across European, Balkan, and Native American herbal traditions as a kidney tonic and diuretic, used for urinary retention, gravel, and kidney inflammation. Preclinical data support antioxidant and diuretic mechanisms relevant to renal protection. No human trials exist.
cornTraditional
Corn silk has been traditionally used for kidney conditions including nephritis, kidney stones, and nephrotoxicity across multiple medical traditions. Preclinical studies show renoprotective effects, including reduction of creatinine and urea levels and protection against nephrotoxic agents. Human clinical evidence remains limited.
cornsilkTraditional
Corn silk (Zea mays stigma) has been used in Native American, Chinese, and European folk medicine for centuries as a diuretic and urinary tract remedy for kidney stones, cystitis, and urinary health. Multiple ethnobotanical and pharmacological reviews support its traditional kidney and urinary applications, with preclinical evidence for diuretic, anti-inflammatory, and anti-urolithic activity. It is recommended in traditional herbal medicine systems across multiple cultures for kidney and urinary stone prevention.
devil's clawTraditional
Devil's Claw has historically been used in southern African folk medicine for liver and kidney disorders. Multiple ethnobotanical and pharmacopoeia references document this traditional use. The British Herbal Pharmacopoeia also recommends it as a diuretic. No clinical trials have evaluated renal outcomes.
dog roseTraditional
Dog Rose has documented traditional use for kidney health and disorders across multiple folk medicine systems, supported by animal evidence showing Rosa canina extract reduced renal oxidative stress markers and kidney stone formation. No controlled human kidney-function trials exist; the evidence is traditional with animal study support.
goji berryTraditional
Goji berry (Lycium barbarum, wolfberry) is a foundational TCM herb used for centuries to tonify kidney essence (Jing) and liver blood, prescribed for kidney deficiency patterns including lower back weakness, tinnitus, and reduced sexual vitality. Preclinical studies show nephroprotective effects against cisplatin and other nephrotoxins, attributed to its polysaccharide (LBP) content and betaine.
gravel rootTraditional
Gravel root has been used in traditional medicine primarily for supporting kidney function, addressing renal irritation, edema, and urinary retention. The Cherokee used it as a kidney remedy. No controlled human studies confirm renal benefits.
horsetailTraditional
Horsetail (Equisetum arvense) has been used in European traditional medicine for centuries as a diuretic herb for kidney and bladder support, including for kidney stones and urinary tract complaints. The European Medicines Agency (EMA) recognizes its traditional use for increasing urine output to aid in minor urinary complaints. Its silica content and mild diuretic action underpin its traditional kidney-supportive role.
milkweedTraditional
Milkweed has an extensively documented traditional use for kidney and urinary problems, including kidney stones and dropsy. Multiple ethnobotanical sources record its use for kidney dysfunction among Indigenous North American peoples. It was listed in 19th-century pharmacopeias for kidney-related conditions. No clinical studies have evaluated this use.
morindaTraditional
Kidney-yang tonification is the foundational traditional Chinese medicine action of M. officinalis ('nourishing the kidney'), applied for kidney deficiency syndromes. Modern pharmacology identifies rutin in M. citrifolia as renal-protective via antioxidant inhibition of ROS and restoration of manganese-SOD and GSH.
partheniumTraditional
Kidney disease is explicitly listed by the NCCIH as a traditional indication for feverfew, documented in folk and traditional medicine use across multiple cultures. No clinical studies of any design have examined feverfew for renal health outcomes.
pennycressTraditional
Traditional healers in Ladakh and European herbalists have documented the use of pennycress seeds for kidney and urinary disorders, including renal inflammation. Nicholas Culpeper specifically described its use for inflammations of the kidneys. No clinical trials have evaluated these uses.
plantagoTraditional
Multiple Plantago species have documented diuretic properties and traditional use for kidney support. P. asiatica is used in TCM as a diuretic. P. major has diuretic properties documented in the ethnobotanical literature. Psyllium (P. ovata) has been studied in CKD animal models for modulating gut-kidney inflammatory axis.
plantainTraditional
Plantago species are used in traditional medicine for kidney-related complaints. Kidney stones are listed among traditional applications. Psyllium fiber from P. ovata seeds demonstrated reduced renal tubular injury in CKD animal models by modulating the gut–kidney axis and reducing uremic toxin accumulation. Evidence is preclinical and traditional for P. major specifically.
prunusTraditional
Prunus africana is widely used in African traditional medicine for kidney disorders, documented in ethnomedicinal surveys across East and Southern Africa. The Medscape drug reference lists kidney disease among its traditional indications. Pharmacological evidence remains largely preclinical; controlled clinical kidney-endpoint trials are lacking.
punarnavaTraditional
Punarnava (Boerhavia diffusa) is synonymous with the Boerhavia diffusa entry and represents a core Ayurvedic kidney herb. It is described separately here as 'punarnava' per the candidate ingredient list.
rose hipsTraditional
Rose hip is documented in European, German, and Traditional Chinese Medicine as a kidney tonic, used to support kidney function through mild diuretic activity, antioxidant protection of renal tissue, and urinary tract cleansing. Traditional monograph sources and ethnobotanical records consistently list kidney support as a primary rose hip use.
sarsaparillaTraditional
Sarsaparilla has a long traditional use as a diuretic and urinary system tonic across Central and South American, Chinese, and European herbal systems. Preclinical evidence (MSKCC) shows renoprotective properties of astilbin in diabetic nephropathy rat models. Human clinical evidence is absent, and Commission E notes potential for kidney irritation at higher doses.
shepherd's purseTraditional
Shepherd's purse has a documented traditional role in supporting kidney function, particularly for hematuria from kidney stones, kidney inflammation, and edema. The PMC 2024 comprehensive review confirms historical use 'to treat edema, hypertension, kidney and nerve disorders.' Its diuretic action and phosphate excretion support are the primary mechanisms cited.
shilajitTraditional
Shilajit (Asphaltum/Mineral pitch) is a classical Ayurvedic mineral-herb preparation documented for thousands of years for kidney support, with properties described as anti-inflammatory, antioxidant, and diuretic. It is traditionally prescribed in Ayurveda for kidney stones, urinary tract conditions, and as a kidney rejuvenator (Mutra Sangrahaniya). Fulvic acid, its primary active component, has been studied for antioxidant and nephroprotective effects.
skullcapTraditional
Native American tribes used S. lateriflora as a 'bitter tonic for the kidneys,' documented in ethnobotanical sources and confirmed by NIH LiverTox. TCM uses S. baicalensis for urinary conditions. No modern pharmacological or clinical evidence specific to kidney function in humans has been verified.
smartweedTraditional
Kidney diseases are among the traditional indications for P. hydropiper documented in ethnomedicinal literature across South and Central Asia. Its diuretic classification in traditional systems directly supports this association.
solomon's sealTraditional
Solomon's seal is documented as a kidney tonic in Ayurvedic medicine, TCM, and Iranian traditional medicine. TCM specifically lists 'tonifying the kidneys' among its key actions. It has been used for kidney stones, gout, and general kidney support across multiple traditions.
teaselTraditional
In TCM, teasel root is considered a primary tonic for the kidneys, viewed as the storehouse of Jing (essential energy). It is used to address kidney deficiency symptoms including fatigue, dizziness, and tinnitus. European herbalists similarly used wild teasel root as a diuretic and for kidney complaints. These uses are traditional and no human clinical renal studies have been published.
terminaliaTraditional
T. chebula is traditionally used in Ayurvedic medicine for kidney and urinary dysfunction, including renal calculi. It is an ingredient in the classical Triphala formula used for liver and kidney dysfunctions as documented in the Ayurvedic Pharmacopoeia. The bark is traditionally used as a diuretic. Animal studies suggest renoprotective antioxidant activity.
tribulusTraditional
Tribulus (Gokshura) is a classical Ayurvedic herb for kidney and urinary health. Preclinical evidence shows renoprotective effects via antioxidant, anti-inflammatory, and diuretic mechanisms. Traditional use for kidney stones, urinary retention, and renal tonic is well-documented across Ayurveda, TCM, and Arabic medicine.
tribulus terrestrisTraditional
Tribulus terrestris (Gokshura) is a classical Ayurvedic herb used for millennia to support kidney and urinary tract health, improve urine flow, and address urinary calculi. It is standard in Ayurvedic protocols for kidney stone prevention and urinary tract strength. Some preclinical studies support its diuretic, anti-urolithic, and anti-inflammatory activities relevant to kidney health.
triphalaTraditional
Triphala (a combination of Terminalia chebula, Terminalia bellerica, and Emblica officinalis) is a classical Ayurvedic polyherbal formula traditionally used to support kidney health by preventing swelling, reducing kidney damage, and supporting urinary tract function. Ayurvedic practitioners have used Triphala as a kidney-protective and detoxifying formula for centuries.
varunaTraditional
Varuna (Crateva nurvala/religiosa) is a classical Ayurvedic herb documented for centuries specifically for kidney stones, urinary tract disorders, and renal health. In Ayurveda, it is prescribed to prevent kidney stone formation, break down existing stones, reduce kidney inflammation, and increase urine output. It is a standard ingredient in Ayurvedic formulas for nephrolithiasis alongside Punarnava and Gokshura.
watermelonTraditional
Watermelon has traditional use in multiple cultures, including traditional Chinese medicine, as a diuretic and kidney-supportive food. Its high water content (92%) promotes urine flow, and citrulline may ease kidney workload by improving renal blood flow. Robust clinical evidence specific to kidney function improvement is limited.
wheat grassTraditional
Wheatgrass is traditionally used for kidney conditions including kidney swelling (nephritis) in naturopathic literature. Animal studies show that wheatgrass extract reduces kidney damage markers (creatinine, urea, BUN) under diabetic and toxic conditions. No human RCT has been conducted for kidney health.
xanthium (cockleburs)Traditional
X. strumarium is described as a diuretic herb with traditional use for urinary tract complaints including painful urination and diseased kidneys in Southwestern US, Indian, and Bangladeshi ethnomedicine. Preclinical diuretic activity has been demonstrated in animal models. However, high doses are documented to cause nephrotoxicity, creating a narrow therapeutic window.